Cardiopulmonary bypass and mitral valve replacement during pregnancy

Perfusion

Volumn 20, Issue 6, 2005, Pages 359-368

  Sutton, Steven W ^a,b   Duncan, Michael A ^a   Chase, Virginia A ^a   Marcel, Randy J ^a   Meyers, Thomas P ^a   Wood, Richard E ^a  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b Baylor University Medical Center ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENOXAPARIN; HEPARIN; MAGNESIUM SULFATE; POTASSIUM CHLORIDE;

ADULT; ALLOTRANSPLANTATION; ANEMIA; ANTICOAGULANT THERAPY; AORTA CLAMPING; ARTICLE; BLOOD DONOR; BLOOD FILTRATION; BODY HEIGHT; BODY SURFACE; BODY WEIGHT; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CASE REPORT; CLINICAL FEATURE; CORRELATION ANALYSIS; DISEASE CONTROL; DISEASE COURSE; DISEASE SEVERITY; ERYTHROCYTE TRANSFUSION; FEMALE; FETOPLACENTAL UNIT; FETUS DISTRESS; FETUS MONITORING; FETUS MORTALITY; FETUS RISK; FIRST TRIMESTER PREGNANCY; FOLLOW UP; GESTATIONAL AGE; HEALTH STATUS; HEART MUSCLE BLOOD FLOW; HEMIPLEGIA; HEMODILUTION; HEMODYNAMIC MONITORING; HEMOFILTRATION; HEPARINIZATION; HIGH RISK PREGNANCY; HUMAN; HYPERKALEMIA; LEUKOCYTE ACTIVATION; LUNG EDEMA; MATERNAL MORTALITY; MATERNAL WELFARE; MEAN ARTERIAL PRESSURE; MEDICAL DECISION MAKING; MITRAL VALVE PROSTHESIS; MITRAL VALVE REGURGITATION; MITRAL VALVE REPLACEMENT; NEUROLOGICAL COMPLICATION; OPERATION DURATION; PRIORITY JOURNAL; PULSATILE FLOW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SURGICAL RISK; TERATOGENESIS; THROMBOCYTE COUNT; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT PLANNING; UTERUS CONTRACTION;

ADULT; CARDIOPULMONARY BYPASS; FEMALE; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; INFANT, NEWBORN; MITRAL VALVE INSUFFICIENCY; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY OUTCOME; PULMONARY EDEMA;

EID: 29244438491     PISSN: 02676591     EISSN: None     Source Type: Journal    
DOI: 10.1191/0267659105pf832oa     Document Type: Article

References (52)

1. DuBourg G, Broustet H, Bricaud H, Fontan F, Tarieux M, Fontanille P. Correction complete d'une triade de Fallot, en circulation extra-corporelle, chez une femme enceinte. Arch Mal Coeur Vaiss 1959; 52: 1389-92.
2. McFaul PB, Dorman JC, Lamki H et al. Pregnancy complicated by maternal heart disease. A review of 519 women. Br J Obstet Gynaecol 1988; 95: 861-67.
3. Parry AJ, Westaby S. Cardiopulmonary bypass during pregnancy. Ann Thorac Surg 1996; 61: 1865-69.
4. Pomini F, Mercogliano D, Cavalletti C, Caruso A, Pomini P. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg 1996; 61: 259-68.
5. Mora CT. Pregnancy and cardiopulmonary bypass, Chapter 24. 359-75.
6. Jacobs WM, Cooley DA, Goen GP. Cardiac surgery with extracorporeal circulation. Report of 3 cases. Obstet Gynecol 1965; 25: 167-69.
7. Zitnik RS, Brandenburg RO, Sheldon R et al. Pregnancy and open heart surgery. Circulation 1969; 39 (suppl 39-40): I-257-62.
8. Becker RM. Intracardiac surgery in pregnant women. Ann Thorac Surg 1983; 36: 453-58.
9. Lapiedra OJ, Bernal JM, Ninot S et al. Open heart surgery for thrombosis of a prosthetic mitral valve during pregnancy: fetal hydrocephalus. J Cardiovasc Surg (Torino) 1986; 27: 217-20.
10. Ueland K. Cardiac surgery and pregnancy. Am J Obstet Gynecol 1965; 92: 148-62.
11. Copper RL, Goldenberg RL, Creasy RK et a]. A multicenter study of preterm. birth weight and gestational age-specific neonatal mortality. Am J Obstet Gynecol 1993; 168: 78-84.
12. Mahli A, Izdes S, Coskun D. Cardiac operations during pregnancy: review of factors influencing fetal outcome. Ann Thorac Surg 2000; 69: 1622-26.
13. Pomini F, Mercogliano D, Cavalletti C, Caruso A, Pomini P. Cardiopulmonary bypass in pregnancy. Ann Thorac Surg 1996; 61: 259-68.
14. Kawkabani N, Kawas N, Baraka A, Vogel T, Mangano CM. Case 3-1999. Severe fetal bradycardia in a pregnant woman undergoing hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1999; 13: 346-49.
15. Leyse R, Ofstun M, Dillard DH et al. Congenital aortic stenosis in pregnancy corrected by extracorporeal circulation. Offering a viable male infant at term with anomalies eventuating in his death at four months of age - report of a case. JAMA 1961; 176: 1009-12.
16. Neri E, Civeli L, Benvenuti A et al. Protected illiofemoral venous thrombectomy in a pregnant woman with pulmonary embolism and ischernic venous thrombosis. Tex Heart Inst J 2002; 29: 130-32.
17. Speekenbrink RG, Bertina RM, Espana F et al. Activation of the protein C system during cardiopulmonary bypass with and without aprotinin. Ann Thorac Surg 1998; 66: 1998-2002.
18. Jensen R, Ens GE. Resistance to activated protein C: a major cause of inherited thrombophilia. Clin Lab Sci 1997; 10: 219-22.
19. Petaja JM, Griffen JH. Activated protein C resistance: what have we learned now that the dust has settled? Ann Med 1997; 29: 469-72.
20. Emmerich J, Alhenc-Gelas M, Aiach M, Fiessinger JN. Activated protein C resistance: role in venous and arterial thrombosis. Arch Mal Coeur Vaiss 1996; 89: 741-45.
21. Abramson N, Abramson S. Hypercoagulability: clinical assessment and treatment. South Med J 2001; 94: 997-1001.
22. Rosenberg RD, Aird WD. Vascular bed specific hemostasis and hypercoagulable states. N Engl J Med 199 340: 1555-64.
23. Heindel SW, Mill MR, Freid EB et al. Fatal thrombosis associated with a hemi-Fontan procedure, heparinprotamine reversal, and aprotinin. Anesthesiology 2001; 94: 369-71.
24. Sharma JB, Nigam M, Tempe A et al. Cesarean section and reoperative mitral valve replacement for thrombosis of a mechanical valve in a 32-week parturient. Acta Obstet Gynecol Scan 2003; 82: 89-90.
25. Oles D, Berryessa R, Campbell K et al. Emergency redo mitral valve replacement in a 27-year-old pregnant female with a clotted prosthetic mitral valve, preoperative fetal demise and postoperative ventricular assist device: a case report. Perfusion 2001; 16: 159-64.
26. Baubiller E, Cherqui D, Dominique C et al. A fatal thrombotic complication during liver transplantation after aprotinin administration. Transplantation 1994; 57: 1664-66.
27. Fitzsimons MG, Peterfreund RA, Raines DE. Aprotinin administration and pulmonary thromboembolism, during orthotopic liver transplantation: report of two cases. Anesth AnaIg 2001; 92: 1418-21.
28. Gitter R, Alivizatos P, Capehart JE et al. Aprotinin and aortic cannula thrombosis. J Thorac Cardiovasc Surg 1996; 112: 537-38.
29. Alvarez JM, Chandraratna H, Newman MA, Levy JH. Case 3-1999. Intraoperative coronary thrombosis in association with low dose aprotinin therapy. J Thorac Cardiothorac Vasc Anesth 1999; 13: 623-28.
30. Bohrer H, Fleischer F, Lang J, Vahl C. Early formation of thrombi on pulmonary artery catheters in cardiac surgical patients receiving high-dose aprotinin. J Cardiothorac Vasc Anesth 1990; 4: 222-25.
31. Royston D. Intraoperative coronary thrombosis: can aprotinin be incriminated? J Cardiothorac Vasc Anesth 1994; 8: 137-41.
32. Smith PK, Muhlbaier LH. Aprotinin: safe and effective only with the full-dose regimen. Ann Thorac Surg 1996; 62: 1575-77.
33. Tubbs RR, Benjamin SP, Dohn DE. Recurrent subarachnoid hemorrhage associated with aminocaproic acid therapy and acute renal artery thrombosis. Case report. J Neurosurg 1979; 51: 94-97.
34. Hoffman EP, Koo AH. Cerebral thrombosis associated with Amicar therapy. Radiology 1979; 131: 687-89.
35. Ramsay MAE, Marcel RJ, Capehart JE, Cheung EH, Ring WS. Massive intravascular thrombosis and thromboembolism after cardiopulmonary bypass. Int J Thorac Cardiovasc Surg 2003; 5(2).
36. Havel M, Gravenwoger F, Scheider J et al. Aprotinin does not decrease early graft patency after coronary artery bypass grafting despite reducing postoperative bleeding and use of donated blood. J Thorac Cardiovasc Surg 1994; 107: 807-10.
37. Hayashida N, Isomura T, Sato T et al. Effects of minimal-dose aprotinin on coronary artery bypass grafting. J Thorac Cardiovasc Surg 1997; 114: 261-69.
38. Shore-Lesserson L, Manspeizer HE, DePerio M et al. Thromboelastography-guided transfusion algorithm reduces transfusions in complex cardiac surgery. Anesth Analg 1999; 88: 312-19.
39. Boldt J, Haisch G, Kumle B et al. Does coagulation differ between elderly and younger patients undergoing cardiac surgery? Intens Care Med 2002; 4: 466-71.
40. Lamarra M, Azzu AA, Kulatilake EN. Cardiopulmonary bypass in the early puerperium: possible new role for aprotinin. Ann Thorac Surg 1992; 54: 361-63.
41. Naqvi TZ, Foster E. Anticoagulation during pregnancy. Curr Womens Health Rep 2002; 2: 95-104.
42. Bony C, Zyka F, Tiran-Rajaofera I, Attali T, De Napoli S, Alessandri JL. Warfarin fetopathy. Arch Pediatr 2002; 9: 705-708.
43. Salazar E, Espinola N, Molina FJ, Reyes A, Barragan R. Heart surgery with cardiopulmonary bypass in pregnant women. Arch Cardiol Mex 2001; 71: 20-27.
44. Elkayam U. Pregnancy and cardiovascular disease. In Braunwald E ed. Heart disease: a textbook of cardiovascular medicine. Philadelphia, PA: Saunders, 2001: 2172-91.
45. Jackson JM, Thomas SJ. Valvular heart disease. In Kaplan JA ed. Cardiac anesthesia, fourth edition. Philadelphia, PA: Saunders, 1999: 727-84.
46. Karahan N, Öztürk T, Yetkin U, Yilik L, Baloglu A, Gürbüz A. Managing severe heart failure in a pregnant patient undergoing cardiopulmonary bypass: case report and review of the literature. J Cardiothorac Vasc Anesthes 2004; 18: 339-43.
47. Rosen MA. Management of anesthesia for the pregnant surgical patient. Anesthesiology 1999; 91: 1159-63.
48. Martin LV, Jurand A. The absence of teratogenic effects of some analgesics used in anesthesia. Additional evidence from a mouse model. Anaesthesia 1992; 47: 473-76.
49. Gopal K, Hudson IM, Ludmir J et al. Homograft aortic root replacement during pregnancy. Ann Thorac Surg 2002; 74: 243-45.
50. Rossouw GJ, Knott-Craig CJ, Barnard PM, Macgregor LA, van Zyl W. Intracardiac operation in seven pregnant women. Ann Thorac Surg 1993; 55: 1172-74.
51. Sudoh Y, Takahara Y, Sunazawa T, Satoh T, Ishikawa H. Emergent mitral valve replacement in the second trimester of pregnancy. Nippon Kyobu Geka Gakkai Zasshi 1997; 45: 1034-38.
52. Tripp HF, Stiegel RM, Coyle JP. The use of pulsatile perfusion during aortic valve replacement in pregnancy. Ann Thorac Surg 1999; 67: 1169-71.